San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Mantra Bio is raising $30,131,370.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Alex Mok played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Mantra Bio

We harness exosomes to deliver safe, highly targeted medicines. We are the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation to generate targeted exosome vehicles (TEVs) for a broad set of therapeutic areas. Exosomes are powerful nano-messengers that comprise nature’s cellular communication network. After decades of scientific discovery, exosomes are being harnessed to form a new class of biologics, exosome therapeutics, enabling unprecedented targeted delivery of therapeutic agents. Importantly, exosome therapeutics have been shown to be safe in many human trials.

To learn more about Mantra Bio, visit http://mantrabio.com/

Contact:
Alex Mok, Chief Executive Officer
415-498-0059
https://www.linkedin.com/in/mokalex/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved